Theravance Biopharma Inc. (TBPH)
NASDAQ: TBPH
· Real-Time Price · USD
9.43
-0.02 (-0.21%)
At close: May 21, 2025, 11:03 AM
-0.21% (1D)
| Bid | 9.42 |
| Market Cap | 471.51M |
| Revenue (ttm) | 65.27M |
| Net Income (ttm) | -58.33M |
| EPS (ttm) | -1.18 |
| PE Ratio (ttm) | -7.99 |
| Forward PE | -8.01 |
| Analyst | Hold |
| Ask | 9.45 |
| Volume | 67,261 |
| Avg. Volume (20D) | 274,413 |
| Open | 9.43 |
| Previous Close | 9.45 |
| Day's Range | 9.22 - 9.43 |
| 52-Week Range | 7.44 - 10.90 |
| Beta | -0.10 |
About TBPH
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TBPH
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TBPH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
-9.29%
Theravance Biopharma shares are trading lower afte...
Unlock content with
Pro Subscription
6 months ago
+8.64%
Theravance Biopharma shares are trading higher after the company reported better-than-expected Q3 sales results.
1 week ago · seekingalpha.com
Theravance Biopharma, Inc. (TBPH) Q1 2025 Earnings Call TranscriptTheravance Biopharma, Inc. (NASDAQ:TBPH ) Q1 2025 Results Conference Call May 8, 2025 5:00 PM ET Company Participants Rick Winningham - Chief Executive Officer Rhonda Farnum - Chief Business Officer A...
2 months ago · seekingalpha.com
Theravance Biopharma, Inc. (TBPH) Q4 2024 Earnings Call TranscriptTheravance Biopharma, Inc. (NASDAQ:TBPH ) Q4 2024 Earnings Conference Call February 26, 2025 5:00 PM ET Company Participants Rick Winningham – Chief Executive Officer Rhonda Farnum – Chief Business Of...
